{"transactions":[{"id":863925,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63030,"kind":"person","name":"Morich Frank","position":1,"cik":"0001748615","reported_name":"Morich Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-03-04T21:38:07.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Issuer's Board of Directors on January 26, 2026, with a grant date of March 2, 2026, and represents the Reporting Person's annual equity award for 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option vests in full on March 2, 2027, subject to the Reporting Person's continued service on the vesting date."}],"balance_after":50000,"derivative":{"exercise_price":5.35,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001748615-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000174861526000002/ownership.xml","form_type":"4"}},{"id":945649,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":63030,"kind":"person","name":"Morich Frank","position":1,"cik":"0001748615","reported_name":"Morich Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-06T21:00:06.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":24400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option becomes fully exercisable on the first anniversary of the grant date."}],"balance_after":24400,"derivative":{"exercise_price":0.34,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":24400},"source":{"system":"sec-edgar","filing":"0001193125-26-004357","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000119312526004357/ownership.xml","form_type":"4"}},{"id":1224986,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63030,"kind":"person","name":"Morich Frank","position":1,"cik":"0001748615","reported_name":"Morich Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-03-05T21:20:00.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Issuer's Board of Directors on February 12, 2025, with a grant date of March 3, 2025, and represents the Reporting Person's annual equity award for 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option vests in full on March 3, 2026, subject to the Reporting Person's continued service on the vesting date."}],"balance_after":50000,"derivative":{"exercise_price":2.46,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950170-25-033626","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000095017025033626/ownership.xml","form_type":"4"}},{"id":1313344,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":63030,"kind":"person","name":"Morich Frank","position":1,"cik":"0001748615","reported_name":"Morich Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-03T21:00:15.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":24400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on January 2, 2025. The option is scheduled to vest as to 50% of the underlying shares on the six-month anniversary of the grant date and as to the remaining 50% on the first anniversary of the grant date."}],"balance_after":24400,"derivative":{"exercise_price":1.09,"expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":24400},"source":{"system":"sec-edgar","filing":"0000950170-25-001107","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000095017025001107/ownership.xml","form_type":"4"}},{"id":1471499,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63030,"kind":"person","name":"Morich Frank","position":1,"cik":"0001748615","reported_name":"Morich Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2024-06-24T20:15:03.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall fully vest on the first anniversary after the Grant Date (06/20/2024), subject to a continued service relationship."}],"balance_after":23000,"derivative":{"exercise_price":10.65,"expiration_date":"2034-06-20","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0000950170-24-076727","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000095017024076727/ownership.xml","form_type":"4"}},{"id":1686910,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":63030,"kind":"person","name":"Morich Frank","position":1,"cik":"0001748615","reported_name":"Morich Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-04T21:00:53.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":24400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on January 2, 2024. The shares underlying the option are scheduled to vest in full on the anniversary date of the grant date."}],"balance_after":24400,"derivative":{"exercise_price":2.78,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":24400},"source":{"system":"sec-edgar","filing":"0000950170-24-001827","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000095017024001827/ownership.xml","form_type":"4"}},{"id":1711785,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63030,"kind":"person","name":"Morich Frank","position":1,"cik":"0001748615","reported_name":"Morich Frank","relationship":{"director":true}}],"security":"Stock Options (right to buy)","published_at":"2023-12-14T23:34:06.000Z","date":"2023-12-12","kind":"grant","planned":false,"acquired":true,"shares":230000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vests 12/12/2024."}],"balance_after":2037471,"derivative":{"exercise_price":0.24,"expiration_date":"2033-12-12","underlying":"Common Stock","underlying_shares":230000},"source":{"system":"sec-edgar","filing":"0001437749-23-034475","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774923034475/rdgdoc.xml","form_type":"4"}},{"id":1997784,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63030,"kind":"person","name":"Morich Frank","position":1,"cik":"0001748615","reported_name":"Morich Frank","relationship":{"director":true}}],"security":"Stock Options (right to buy)","published_at":"2023-02-24T00:35:06.000Z","date":"2023-02-21","kind":"grant","acquired":true,"shares":230000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% vests 2/21/2024."}],"balance_after":1807471,"derivative":{"exercise_price":0.38,"expiration_date":"2033-02-21","underlying":"Common Stock","underlying_shares":230000},"source":{"system":"sec-edgar","filing":"0001437749-23-004436","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774923004436/rdgdoc.xml","form_type":"4"}},{"id":1997783,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63030,"kind":"person","name":"Morich Frank","position":1,"cik":"0001748615","reported_name":"Morich Frank","relationship":{"director":true}}],"security":"Stock Options (right to buy)","published_at":"2023-02-24T00:35:06.000Z","date":"2023-02-21","kind":"grant","acquired":true,"shares":470000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vest monthly over three years."}],"balance_after":1577471,"derivative":{"exercise_price":0.38,"expiration_date":"2033-02-21","underlying":"Common Stock","underlying_shares":470000},"source":{"system":"sec-edgar","filing":"0001437749-23-004436","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774923004436/rdgdoc.xml","form_type":"4"}},{"id":2061651,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":63030,"kind":"person","name":"Morich Frank","position":1,"cik":"0001748615","reported_name":"Morich Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-05T21:11:49.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on January 3, 2023.  The shares underlying the option are scheduled to vest in full on the anniversary date of the grant date."}],"balance_after":10000,"derivative":{"exercise_price":2.66,"expiration_date":"2033-01-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-23-001796","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919123001796/doc4.xml","form_type":"4"}},{"id":2250848,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":63030,"kind":"person","name":"Morich Frank","position":1,"cik":"0001748615","reported_name":"Morich Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-31T20:06:33.000Z","date":"2022-05-27","kind":"purchase","acquired":true,"shares":28000,"price":3.75,"value":105000.0,"ownership":{"direct":true},"balance_after":28000,"source":{"system":"sec-edgar","filing":"0001209191-22-032800","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919122032800/doc4.xml","form_type":"4"}},{"id":2442717,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":63030,"kind":"person","name":"Morich Frank","position":1,"cik":"0001748615","reported_name":"Morich Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-06T01:25:36.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on January 3, 2022.  The shares underlying the option are scheduled to vest in full on the anniversary of the grant date."}],"balance_after":10000,"derivative":{"exercise_price":12.28,"expiration_date":"2032-01-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-22-001051","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000089924322001051/doc4.xml","form_type":"4"}},{"id":2914577,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":63030,"kind":"person","name":"Morich Frank","position":1,"cik":"0001748615","reported_name":"Morich Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-01-06T21:41:10.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on January 4, 2021. The shares underlying the option are scheduled to vest in full on the anniversary of the grant date."}],"balance_after":10000,"derivative":{"exercise_price":12.36,"expiration_date":"2031-01-03","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-21-000705","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000089924321000705/doc4.xml","form_type":"4"}},{"id":3152122,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":63030,"kind":"person","name":"Morich Frank","position":1,"cik":"0001748615","reported_name":"Morich Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-12T20:18:43.000Z","date":"2020-05-11","kind":"grant","acquired":true,"shares":1200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock option award granted on May 11, 2020 pursuant to the Issuer's 2016 Omnibus Incentive Plan."}],"balance_after":1200,"derivative":{"exercise_price":27.56,"exercise_date":"2020-12-31","expiration_date":"2030-05-11","underlying":"Common Stock","underlying_shares":1200},"source":{"system":"sec-edgar","filing":"0001209191-20-028490","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919120028490/doc4.xml","form_type":"4"}},{"id":3317396,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":63030,"kind":"person","name":"Morich Frank","position":1,"cik":"0001748615","reported_name":"Morich Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-01-06T23:01:08.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock option award granted on January 2, 2020 pursuant to the Issuer's Director Compensation Policy."}],"balance_after":8000,"derivative":{"exercise_price":16.31,"exercise_date":"2021-01-02","expiration_date":"2030-01-02","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-20-002064","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919120002064/doc4.xml","form_type":"4"}},{"id":3707172,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":63030,"kind":"person","name":"Morich Frank","position":1,"cik":"0001748615","reported_name":"Morich Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-01-03T23:40:18.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8000,"derivative":{"exercise_price":5.16,"exercise_date":"2020-01-02","expiration_date":"2026-01-02","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-19-001333","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919119001333/doc4.xml","form_type":"4"}},{"id":3854563,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":63030,"kind":"person","name":"Morich Frank","position":1,"cik":"0001748615","reported_name":"Morich Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-08-02T21:09:17.000Z","date":"2018-07-31","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These Stock Options become exercisable in eight equal semi-annual installments beginning January 31, 2019."}],"balance_after":50000,"derivative":{"exercise_price":9.06,"expiration_date":"2025-07-31","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-18-045015","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919118045015/doc4.xml","form_type":"4"}}]}